Gerri Henwood
2020 - Recro Pharma
In 2020, Gerri Henwood earned a total compensation of $441.1K as Former President and Chief Executive Officer at Recro Pharma, a 90% decrease compared to previous year.
Compensation breakdown
Bonus | $111,240 |
---|---|
Salary | $308,654 |
Other | $21,166 |
Total | $441,060 |
Henwood received $308.7K in salary, accounting for 70% of the total pay in 2020.
Henwood also received $111.2K in bonus and $21.2K in other compensation.
Rankings
In 2020, Gerri Henwood's compensation ranked 11,343rd out of 13,090 executives tracked by ExecPay. In other words, Henwood earned more than 13.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,343 out of 13,090 | 13th |
Division Manufacturing | 4,865 out of 5,624 | 14th |
Major group Chemicals And Allied Products | 2,016 out of 2,257 | 11th |
Industry group Drugs | 1,759 out of 1,957 | 10th |
Industry Pharmaceutical Preparations | 1,302 out of 1,462 | 11th |
Source: SEC filing on March 25, 2021.
Henwood's colleagues
We found two more compensation records of executives who worked with Gerri Henwood at Recro Pharma in 2020.
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019